Home › Funds › LMR Partners LLP › MRNA

LMR Partners LLP position in MRNA

MODERNA INC · Health Care

LMR Partners LLP reported holding 293,300 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$56.5M, representing 0.52% of its reported portfolio and ranking #31 among its reported holdings. LMR Partners LLP has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)293.30K sh
Reported value held$56.48M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How LMR Partners LLP's MRNA position evolved

LMR Partners LLP first disclosed a stake in MRNA in Q3 2023 at 35,000 shares (US$3.6M). The position peaked in Q3 2026 at 293,300 shares, worth US$56.5M. Across 13 filings, LMR Partners LLP increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 293,300 shares valued at US$56.5M — an increase of 230,245 shares quarter over quarter.. Notable position changes include a 339% increase in Q2 2025 (shares fell 6% over the following quarter), a 8921% increase in Q2 2026 (shares rose 175% over the following quarter), a 365% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.00K $3.62M New
Q4 2023 10.00K $994.50K Reduce
Q1 2024 20.00K $2.13M Add
Q2 2024 53.90K $6.40M Add
Q3 2024 115.50K $7.72M Add
Q4 2024 21.00K $873.18K Reduce
Q1 2025 11.40K $323.19K Reduce
Q2 2025 50.00K $1.38M Add
Q3 2025 32.81K $847.46K Reduce
Q4 2025 103.77K $3.06M Add
Q1 2026 699 $35.51K Reduce
Q2 2026 63.05K $4.42M Add
Q3 2026 293.30K $56.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 47 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has LMR Partners LLP held MRNA?

LMR Partners LLP has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LMR Partners LLP's current position in MRNA?

As of Q3 2026, LMR Partners LLP holds 293.30K shares of MRNA (MODERNA INC), valued at $56.48M, representing 0.52% of its reported portfolio and ranking #31.

Has LMR Partners LLP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), LMR Partners LLP increased its position in MRNA. The position peaked in Q3 2026 at 293.30K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.